Christodoulopoulos P, Wright E, Frenkiel S, Luster A, Hamid Q
Meakins-Christie Laboratories, Montreal, Quebec, Canada.
J Allergy Clin Immunol. 1999 Jun;103(6):1036-44. doi: 10.1016/s0091-6749(99)70176-4.
Human allergen-induced rhinitis is associated with the recruitment and activation of inflammatory cells, particularly eosinophils and CD4(+) T cells, in the nasal mucosa. Chemokines are inflammatory mediators capable of attracting specific inflammatory cell populations. Monocyte chemotactic proteins (MCPs), a subfamily of CC chemokines, have been shown to induce chemotactic activity particularly in eosinophils, T cells, and monocytes under in vitro assay conditions.
To assess the contribution of MCPs in the recruitment of inflammatory cells in vivo, we investigated the allergen-induced late response in subjects with allergic rhinitis.
Patients were randomized to receive a 6-week treatment with either topical corticosteroid (n = 6) or a matched placebo (n = 6). Nasal inferior turbinate biopsy specimens were obtained from all subjects before and during allergen-induced late responses. By using immunocytochemistry, tissue sections were examined for the presence of MCP-1, MCP-3, and MCP-4 and for the phenotype of infiltrating cells within the nasal mucosa. In addition, double sequential immunocytochemistry was used to confirm the phenotype of MCP-immunoreactive positive cells. Furthermore, the effect of topical corticosteroids on the expression of MCPs and on the cellular infiltrate was also examined.
MCP-1, MCP-3, and MCP-4 were expressed in all the baseline samples, with prominent staining observed within the nasal epithelium. Biopsy specimens taken after challenge exhibited significant upregulation in the expression of MCP-3 and MCP-4 (P <.001). On the other hand, this increase in response to allergen was reduced in patients pretreated with topical corticosteroids. Colocalization experiments revealed that the majority of MCP+ cells in the subepithelium were macrophages, followed by T cells and eosinophils.
Our results demonstrate that allergen-induced rhinitis is associated with an increased expression of MCP-3 and MCP-4, which may be closely related to the influx of inflammatory cells and may thus contribute to the pathogenesis of allergic rhinitis.
人类变应原诱导的鼻炎与鼻黏膜中炎症细胞,特别是嗜酸性粒细胞和CD4(+) T细胞的募集和活化有关。趋化因子是能够吸引特定炎症细胞群体的炎症介质。单核细胞趋化蛋白(MCPs)是CC趋化因子的一个亚家族,已显示在体外试验条件下能诱导趋化活性,特别是在嗜酸性粒细胞、T细胞和单核细胞中。
为了评估MCPs在体内炎症细胞募集中的作用,我们研究了变应性鼻炎患者变应原诱导的迟发反应。
患者被随机分为两组,一组接受为期6周的局部皮质类固醇治疗(n = 6),另一组接受匹配的安慰剂治疗(n = 6)。在变应原诱导的迟发反应之前和期间,从所有受试者获取下鼻甲活检标本。通过免疫细胞化学方法,检查组织切片中MCP-1、MCP-3和MCP-4的存在情况以及鼻黏膜内浸润细胞的表型。此外,采用双重连续免疫细胞化学方法来确认MCP免疫反应阳性细胞的表型。此外,还研究了局部皮质类固醇对MCPs表达和细胞浸润的影响。
所有基线样本中均表达MCP-1、MCP-3和MCP-4,在鼻上皮内观察到明显的染色。激发后获取的活检标本显示MCP-3和MCP-4的表达显著上调(P <.001)。另一方面,在接受局部皮质类固醇预处理的患者中,这种对变应原的反应性增加有所降低。共定位实验显示,上皮下大多数MCP+细胞为巨噬细胞,其次是T细胞和嗜酸性粒细胞。
我们的结果表明,变应原诱导的鼻炎与MCP-3和MCP-4的表达增加有关,这可能与炎症细胞的流入密切相关,从而可能参与变应性鼻炎的发病机制。